DropletPharm Inc.

Sherman Oaks, CA · Medtech

Microfluidic droplet-based platform for automated PET radiopharmaceutical synthesis

Grants
$838K
3 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Microchip electrophoresis as basis for fully integrated, fully automated, low-cost radiopharmaceutical QC platform$275,766
Federal grantDepartment of Health and Human Services · Phase I · Production of radiometal-based radiopharmaceuticals at a clinical scale via droplet-scale radiochemistry$275,773
Federal grantDepartment of Health and Human Services · Phase I · Demonstrating miniaturized production of a KOR PET tracer as a proof-of-concept for low-cost distribution of nascent PET neurotracers$286,331
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1083PROTEUS MOTION INC.—$16M
1084Altis Biosystems, Inc.—$4.4M
1085Orange Photonics, Inc.—$1.9M
1086DropletPharm Inc.——
1087EMANATE WIRELESS, INC.—$1.0M
1088PSYONIC, Inc.—$150K
1089Eye Academy of America Ltd.—$4.0M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.